
This is not the first instance in which J&J’s Risperdal led to litigation and the possibility of former Commissioner David Kessler’s testimony. Johnson & Johnson settled an earlier case in 2012 before the commissioner was able to testify. Although he never testified in that case, his written report was states, “Janssen promoted Risperdal for non-approved uses in violation of the Federal Food, Drug, and Cosmetic Act. The promotion of non-approved uses by a manufacturer, because it undercuts the system and safeguards of drug regulation, is concerning.” He was the commissioner of the FDA for a total of seven years from 1990 to 1997.
The Risperdal lawsuit specifically targets the pharmaceutical arm of Johnson & Johnson, known as Janssen.

If you or a loved one has been diagnosed with gynecomastia following use of Risperdal, you should speak with a Risperdal lawyer to discuss your legal options. The pharmaceutical lawyers of Lopez McHugh can help you make sure that drug makers are held responsible for damages they may have caused. Contact a Lopez McHugh attorney today at (877) 737-8525 or fill out a contact form on our website for a free initial consultation.
